FDA Phases Out Animal Testing: React4life at the Forefront of Drug Innovation
The FDA’s move to phase out animal testing in monoclonal…
MIVO® vs. Microfluidic Lab-on-Chip: Why Size Matters in Advanced Drug Development
MIVO® represents a major advancement in organ-on-chip…
“Femininity without compromise. Innovation is never conventional”, the editorial project that involved our founder Silvia Scaglione.
Silvia Scaglione, Chief Scientist at React4life, recognized…
Personalized Cancer Therapy: The Future of Precision Medicine with MIVO® Organ-on-Chip Technology
MIVO® Organ-on-Chip technology elevates personalized cancer…
Covid19 and heart: an advanced in vitro research on infection mechanism
Cardio-Cov, a research project funded by Regione Lombardia…
